0001778748-19-000001.txt : 20190604 0001778748-19-000001.hdr.sgml : 20190604 20190604165651 ACCESSION NUMBER: 0001778748-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190604 DATE AS OF CHANGE: 20190604 EFFECTIVENESS DATE: 20190604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Illumina Radiopharmaceuticals LLC CENTRAL INDEX KEY: 0001778748 IRS NUMBER: 834571497 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-341138 FILM NUMBER: 19877368 BUSINESS ADDRESS: STREET 1: C/O CTSW 420 LEXINGTON AVENUE STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-381-8749 MAIL ADDRESS: STREET 1: C/O CTSW 420 LEXINGTON AVENUE STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10170 D 1 primary_doc.xml X0708 D LIVE 0001778748 Illumina Radiopharmaceuticals LLC C/O CTSW 420 LEXINGTON AVENUE SUITE 2400 NEW YORK NY NEW YORK 10170 212-381-8749 DELAWARE Fluoro Diagnostics LLC None Limited Liability Company true 2019 Scott J. Korman c/o CTSW 420 Lexington Avenue Suite 2400 NEW YORK NY NEW YORK 10170 Executive Officer David Turner c/o CTSW 420 Lexington Avenue Suite 2400 New York NY NEW YORK 10170 Executive Officer David Battleman c/o CTSW 420 Lexington Avenue Suite 2400 New York NY NEW YORK 10170 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2019-05-17 false true Units representing Limited Liability Company Interests false 25000 Pickwick Capital Partners, LLC 130672 Pickwick Capital Partners, LLC 130672 445 Hamilton Avenue Suite 1102 White Plains NY NEW YORK 10601 NJ NEW JERSEY NY NEW YORK false 9000000 250000 8750000 false 1 0 0 Sales Commissions are 9% for monies raised and closed. 180000 true The management team, in the aggregate, is to be paid $30,000 per month until the anticipated closing of the offering in October 2019. false Illumina Radiopharmaceuticals LLC /S/ Scott Korman Scott Korman Managing Member 2019-06-04